| |
The CRO Awards recognize Contract Research Organizations (CROs) for their exceptional contributions to clinical research and development. These awards honor CROs that excel in innovation, quality, and leadership, highlighting their crucial role in advancing life sciences and improving patient outcomes. LEARN MORE AND ENTER
|
|
Today’s Big NewsSep 5, 2024 |
|
September 9-12, 2024 | Philadelphia, PA Join us at Digital Pharma East, the leading event for digital innovation in the pharmaceutical industry. Dive into key topics including Digital Marketing, Data & Analytics, and Patient Engagement. Learn from industry experts, network with peers, and explore cutting-edge strategies to drive your digital initiatives forward. Only 1 WEEK LEFT to Join us in Philadelphia!
|
|
| By Gabrielle Masson Lykos CEO and founder Amy Emerson is stepping down, with Chief Operating Officer Michael Mullette taking over the top spot on an interim basis. |
|
|
|
By Zoey Becker The drugmaker laid off 20 employees as it attempts to recoup from dwindling funds during its Anktiva launch in bladder cancer. |
By Conor Hale The wellness-focused Lingo received the FDA’s blessing earlier this year, as one of the company’s first wearable blood sugar trackers to be offered without a prescription. |
By Ben Adams It’s as you were at the top of the TV drug ad spending table as AbbVie continues its 2024 domination as total spending across the top 10 pharma companies rebounds from its summer lull. |
|
Shape the Future of Life Sciences Submissions for the Fierce Life Sciences Innovation Awards are coming to a close September 5th, 2024. Click to submit your entry for our new 2024 category: AI Innovation. Enter now!
|
|
By Nick Paul Taylor Eli Lilly has vaulted into an AI-enabled drug discovery deal, partnering with RNA specialist Genetic Leap in a pact worth up to $409 million in upfront and milestone payments. |
By Zoey Becker The company's game plan includes five new indications for dwarfism drug Voxzogo through 2031, which could represent a $5 billion opportunity covering a patient population of 420,000. |
By Fraiser Kansteiner Early Thursday, Lilly unveiled positive topline results from a pair of phase 3 trials—QWINT-1 and QWINT-3—assessing its once-a-week basal insulin candidate called efsitora alfa. Both studies met their primary endpoints, with efsitora achieving non-inferior A1C reductions when pitted against two common daily insulins. |
By Andrea Park In an attempt to stanch the flow of false beliefs about dementia, which may manifest as a lack of awareness about risk reduction options or poor treatment of those diagnosed with dementia, the United Nations’ Pan American Health Organization has launched a new campaign that’ll dole out information about the condition, its causes and its effects on everyday life. |
By Fraiser Kansteiner Glenmark will pay the U.S. Department of Justice $25 million to resolve claims that it worked with other drugmakers to rig prices of the cholesterol med pravastatin. The case forms part of a larger antitrust probe implicating numerous manufacturers. |
By Gabrielle Masson Astellas Pharma has cut the ribbon on a new life sciences center in Massachusetts that will house 400 team members and an incubator lab. |
By Joseph Keenan After years of documentation and industry neglect, the World Health Organization issued its first-ever guidance aimed at addressing wastewater and solid waste from antibiotic manufacturers that is linked to antimicrobial resistance. |
By Darren Incorvaia The bacterium Clostridioides difficile is one of the most common infections picked up in hospitals, and, even once it’s cleared from the body, patients have a 1 in 6 chance of catching it again within a couple of months. It also often resists antibiotic treatment, leaving it free to infect the colon and cause diarrhea, nausea, fever and, in severe cases, sepsis and death. |
By Nick Paul Taylor The Leukemia & Lymphoma Society has marked National Blood Cancer Awareness Month with its 31st annual Light The Night campaign—and put its recently installed top pharma sponsor of the events in the spotlight. |
Fierce podcastsDon’t miss an episode |
| | In this week's episode of "The Top Line," we look at factors driving the continuing decline of flu vaccination rates in the U.S. and beyond. |
|
|---|
|
|
|
Wednesday, September 24, 2024 | 11am ET / 8am PT In this webinar, we will explore how real-world healthcare data and artificial intelligence can provide key insights into the hidden aspects of patient journeys. Register now.
|
|
| WhitepaperWe interviewed dozens of biopharma leaders on the critical success factors for building a Best Practice commercial organization. This report shares what we learned. Sponsored by: Blue Matter Consulting |
| WhitepaperFinding an effective epilepsy treatment can be arduous. Download this brochure to delve into how IQVIA's expertise and innovative strategic approach can streamline the clinical trial process, helping to get new therapies to patients who need them sooner. Sponsored by: IQVIA |
On Helix Date: 4 July 2024 - Location: Babraham Research Campus, Cambridge UK |
|
| |
|
